ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,566Medicare Part D Prescriptions Filled, Including Refills

Rank: 154 out of 1006

$585K Total Retail Price of All Prescriptions

Rank: 166 out of 1006

388 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
46% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 388 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

10% of this provider’s 388 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 7,667 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$68 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
ATORVASTATIN CALCIUM 319 283 1 5
LEVOTHYROXINE SODIUM 287 217 2 2
LISINOPRIL 287 270 2 3
FUROSEMIDE 250 236 4 6
WARFARIN SODIUM 234 232 5 8
OMEPRAZOLE 211 170 6 9
SIMVASTATIN 210 186 7 1
AMLODIPINE BESYLATE 207 204 8 4
HYDROCODONE-ACETAMINOPHEN 184 170 S3 9 25
HYDROCHLOROTHIAZIDE 163 160 10 11
METOPROLOL SUCCINATE 158 158 11 12
METOPROLOL TARTRATE 143 141 12 7
PREDNISONE 141 129 13 33
ESCITALOPRAM OXALATE 138 138 14 27
ATENOLOL 125 121 15 13
ALLOPURINOL 116 116 16 31
DIOVAN 109 109 17 16
GABAPENTIN 106 99 18 20
MELOXICAM 106 100 18 67
NEXIUM 96 81 20 28
EVISTA 95 95 21 169
TAMSULOSIN HCL 93 92 22 23
QUETIAPINE FUMARATE 90 90 23 45
AZITHROMYCIN 89 82 24 39
SPIRIVA 85 85 25 48
TRAZODONE HCL 81 70 26 21
SERTRALINE HCL 81 80 26 19
DIGOXIN 78 78 28 52
CARISOPRODOL 73 56 R 29 172
CIPROFLOXACIN HCL 67 63 30 75
CLOPIDOGREL 65 65 31 46
TRIAMCINOLONE ACETONIDE 64 62 32 135
DIVALPROEX SODIUM 61 38 33 53
NADOLOL 61 54 33 256
LYRICA 60 60 35 115
DONEPEZIL HCL 59 59 36 17
ZOLPIDEM TARTRATE 57 55 37 14
LANTUS SOLOSTAR 57 57 37 93
QUINAPRIL HCL 55 55 39 86
CITALOPRAM HBR 55 53 39 24
MIRTAZAPINE 54 54 41 26
FLUOXETINE HCL 51 51 42 85
CRESTOR 51 51 42 18
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 6, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.